| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
90,552,000 |
| Market
Cap: |
3.04(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$18.07 - $59.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 8 |
| Insider 3/6 Months : 8.6 |
|
| Guru Rank Number : 538 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile PTC Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. Co. has the following products, Translarna™ (ataluren) and Emflaza® (deflazacort), for the treatment of Duchenne muscular dystrophy, a rare, life threatening disorder. Co.'s gene therapy product candidates for rare monogenic diseases that affect the central nervous system (CNS) include PTC- Aromatic L-Amino Acid Decarboxylase (AADC) for the treatment of AADC deficiency, a rare CNS disorder arising from reductions in the enzyme AADC that results from mutations in the dopa decarboxylase gene.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
7,700 |
7,700 |
7,700 |
| Total Buy Value |
$0 |
$198,736 |
$198,736 |
$198,736 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
1 |
1 |
| Total Shares Sold |
5,981 |
52,172 |
114,858 |
280,340 |
| Total Sell Value |
$151,224 |
$1,447,501 |
$4,819,149 |
$12,887,777 |
| Total People Sold |
3 |
8 |
10 |
15 |
| Total Sell Transactions |
4 |
26 |
35 |
88 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pauwels Eric |
CHIEF BUSINESS OFFICER |
• – – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
68,363 |
|
- |
|
| Klein Matthew B. |
CHIEF OPERATING OFFICER |
• – – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
83,104 |
|
- |
|
| Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
• – – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
I/I |
710 |
3,428 |
|
- |
|
| Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
• – – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
66,151 |
|
- |
|
| Smith Mary L. |
|
– • – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
9,813 |
|
- |
|
| Okey Stephanie |
|
– • – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
5,867 |
|
- |
|
| Hill Emily Luisa |
CHIEF FINANCIAL OFFICER |
• – – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
19,500 |
48,759 |
|
- |
|
| Schmertzler Michael |
|
– • – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
117,766 |
|
- |
|
| Southwell David P |
|
– • – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
10,500 |
|
- |
|
| Boulding Mark Elliott |
EXEC. VP AND CLO |
• – – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
78,110 |
|
- |
|
| Boulding Mark Elliott |
EXEC. VP AND CLO |
• – – |
2022-10-18 |
4 |
AS |
$55.04 |
$16,462 |
D/D |
(299) |
61,110 |
|
-8% |
|
| Boulding Mark Elliott |
EXEC. VP AND CLO |
• – – |
2022-10-18 |
4 |
OE |
$30.86 |
$9,227 |
D/D |
299 |
61,399 |
|
- |
|
| Boulding Mark Elliott |
EXEC. VP AND CLO |
• – – |
2022-10-17 |
4 |
AS |
$55.00 |
$363,110 |
D/D |
(6,602) |
61,110 |
|
-17% |
|
| Boulding Mark Elliott |
EXEC. VP AND CLO |
• – – |
2022-10-17 |
4 |
OE |
$30.86 |
$203,738 |
D/D |
6,602 |
67,512 |
|
- |
|
| Boulding Mark Elliott |
EXEC. VP AND CLO |
• – – |
2022-09-20 |
4 |
AS |
$55.00 |
$64,680 |
D/D |
(1,176) |
61,110 |
|
-10% |
|
| Boulding Mark Elliott |
EXEC. VP AND CLO |
• – – |
2022-09-20 |
4 |
OE |
$30.86 |
$36,291 |
D/D |
1,176 |
61,410 |
|
- |
|
| Okey Stephanie |
|
– • – |
2022-08-09 |
4 |
S |
$51.62 |
$118,522 |
D/D |
(2,296) |
1,867 |
|
24% |
|
| Graham Dawn |
|
– • – |
2022-06-09 |
4 |
S |
$27.20 |
$20,074 |
D/D |
(738) |
29,017 |
|
-58% |
|
| Young Alethia |
|
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,067 |
5,067 |
|
- |
|
| Klein Matthew B. |
CHIEF OPERATING OFFICER |
• – – |
2022-04-19 |
4 |
S |
$42.52 |
$38,136 |
D/D |
(897) |
56,564 |
|
-14% |
|
| Pauwels Eric |
CHIEF BUSINESS OFFICER |
• – – |
2022-04-19 |
4 |
S |
$42.52 |
$34,947 |
D/D |
(822) |
49,772 |
|
-14% |
|
| Boulding Mark Elliott |
EXEC. VP AND CLO |
• – – |
2022-04-05 |
4 |
AS |
$45.00 |
$225 |
D/D |
(5) |
61,110 |
|
21% |
|
| Boulding Mark Elliott |
EXEC. VP AND CLO |
• – – |
2022-04-05 |
4 |
OE |
$11.23 |
$56 |
D/D |
5 |
61,115 |
|
- |
|
| Hill Emily Luisa |
CHIEF FINANCIAL OFFICER |
• – – |
2022-03-31 |
4 |
AS |
$37.78 |
$298,824 |
D/D |
(7,910) |
29,259 |
|
44% |
|
| Boulding Mark Elliott |
Exec. VP and CLO |
• – – |
2022-02-10 |
4 |
AS |
$45.03 |
$807,559 |
D/D |
(17,935) |
61,110 |
|
-18% |
|
524 Records found
|
|
Page 6 of 21 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.54 (1.58%) 
